CE 139 Pill - orange capsule/oblong
Pill with imprint CE 139 is Orange, Capsule/Oblong and has been identified as Imatinib Mesylate 400 mg. It is supplied by Chartwell RX, LLC.
Imatinib is used in the treatment of Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Chronic Eosinophilic Leukemia; Dermatofibrosarcoma Protuberans; Gastrointestinal Stromal Tumor and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Imatinib 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CE 139
Imatinib Mesylate
- Imprint
- CE 139
- Strength
- 400 mg
- Color
- Orange (light Orange)
- Shape
- Capsule/Oblong (film-coated, biconvex with beveled edges)
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Chartwell RX, LLC
- National Drug Code (NDC)
- 62135-0659
More about imatinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (47)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
